Storage and handling
Other Information Protect the product in this container from excessive heat and direct sun
No7 Beautiful Skin Day Normal Oily Sunscreen Broad Spectrum SPF 15
- Manufacturer
- Boots Retail USA Inc | The Boots Company PLC | BCM Ltd
- Effective date
- 2012-05-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:41
Label at a glance#
ProductNo7 Beautiful Skin Day Normal Oily Sunscreen Broad Spectrum SPF 15
Active ingredientAvobenzone, Octisalate, Octocrylene
Label structure17 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com/no7
www.boots.com/no7Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Aqua (water), C12-15 alkyl benzoate, Glycerin, Alcohol denat., Cetearyl glucoside, Cyclopentasiloxane, Dimethicone, Cyclohexasiloxane, Tribehenin, Cetearyl alcohol, Methyl methacrylate cross-polymer, Ammonium acryloyldimethyltaurate/VP copolymer, Phenoxyethanol, Tocopheryl acetate, Potassium cetyl phosphate, Dimethiconol, Parfum (Fragrance), Methylparaben, Ethylparaben, Sodium PCA, Xanthan gum, Alcohol, Zinc PCA, Ascorbyl glucoside, Tetrasodium EDTA, Magnesium PCA, T-butyl alcohol, Dipropylene glycol, Hamamelis virginiana (Witch hazel) water, Potassium hydroxide, Manganese PCA, Simethicone, Potassium sorbate
OTC - QUESTIONS SECTION
USA: Questions? 1-866-75-BOOTS
The Boots Company PLC Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc. Norwalk CT 06851 USA
Made in the UK
DESCRIPTION SECTION
A light moisture cream to hydrate whilst balancing oil production. Instantly mattifies for shine free healthy looking radiant skin. The protective power of SPF 15 and broad spectrum sunscreens give you advanced protection for the future and and help keep you looking as young as possible.
Hypo-allergenic: Because all skin can have sensitive moments all our products are hypo-allergenic, using ingredients we know and trust.
DESCRIPTION SECTION
For Best Results: Smooth into your face and neck after cleansing every morning for make-up ready skin.
Enriched with No7's unique multivitamin and mineral blend to help hydrate and energise skin plus zinc to help regulate oil production.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Avobenzone 3%, Octisalate 2%, Octocrylene 4%
Purpose
Sunscreen
OTC - PURPOSE SECTION
Uses
Helps prevent sunburn
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away
INSTRUCTIONS FOR USE SECTION
Directions
Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
Children under 6 months of age: ask a doctor
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun, especially from 10a.m. - 2p.m.
wear long-sleeved shirts, pants, hat and sunglasses
STORAGE AND HANDLING SECTION
Other Information
Protect the product in this container from excessive heat and direct sun
INSTRUCTIONS FOR USE SECTION
JAR TEXT
Smooth into your face and neck after cleansing every morning
WARNINGS SECTION
JAR TEXT
Warning: Avoid contact with eyes. If product gets into the eyes, rinse well with water immediately.
OTC - ACTIVE INGREDIENT SECTION
JAR TEXT
Active ingredients: Octocrylene 4%, Avobenzone 3%, Octisalate 2%.
INFORMATION FOR PATIENTS SECTION
JAR TEXT
The Boots Company PLC
Nottingham England NG2 3AA
Dist. in the USA by Boots Retail USA Inc.
Norwalk CT 06851 USA
Made in the UK
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
No7 Beautiful Skin
Day Cream / Normal/OIly
Hydrates, balances and mattifies for healthy looking radiant skin
Sunscreen Broad Spectrum SPF 15
50ml 1.6 US Fl.Oz.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
No7 Beautiful Skin
Day Cream
Normal/Oily
Hypo-allergenic
Sunscreen Broad Spectrum SPF 15
50ml 1.6 US Fl.Oz.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68472-105-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d451-f6ea-e053-dbdaa90aa703 | Carton and jar labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68472-105-01 | No7 Beautiful Skin Day Normal Oily Sunscreen Broad Spectrum SPF 15 | 50 mL in 1 JAR | CREAM | 50 | 1 | |
| 68472-105-01 | No7 Beautiful Skin Day Normal Oily Sunscreen Broad Spectrum SPF 15 | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68472-105 | NO7 BEAUTIFUL SKIN DAY NORMAL OILY SUNSCREEN BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) CREAM [BOOTS RETAIL USA INC] | 1 | Legacy NDC, 2 package rows | 20120504_d0db8c4e-2e41-41dd-81fb-65e008b96acd.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| ASCORBYL GLUCOSIDE | INACTIVE INGREDIENT | 2V52R0NHXW | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HAMAMELIS VIRGINIANA TOP WATER | INACTIVE INGREDIENT | NT00Y05A2V | 1 | |
| MAGNESIUM PIDOLATE | INACTIVE INGREDIENT | V5PC588N7G | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 1 | |
| TERT-BUTYL ALCOHOL | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 | |
| ZINC PIDOLATE | INACTIVE INGREDIENT | C32PQ86DH4 | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Beautiful Skin Day Normal Oily Sunscreen Broad Spectrum SPF 15
- Avobenzone, Octisalate and Octocrylene
- Avobenzone
- Octisalate
- Octocrylene
- Water
- ALKYL (C12-15) BENZOATE
- GLYCERIN
- Alcohol
- CETEARYL GLUCOSIDE
- CYCLOMETHICONE 5
- Dimethicone
- CYCLOMETHICONE 6
- TRIBEHENIN
- CETOSTEARYL ALCOHOL
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- PHENOXYETHANOL
- .ALPHA.-TOCOPHEROL ACETATE
- POTASSIUM CETYL PHOSPHATE
- METHYLPARABEN
- ETHYLPARABEN
- SODIUM PYRROLIDONE CARBOXYLATE
- XANTHAN GUM
- ZINC PIDOLATE
- ASCORBYL GLUCOSIDE
- EDETATE SODIUM
- MAGNESIUM PIDOLATE
- TERT-BUTYL ALCOHOL
- DIPROPYLENE GLYCOL
- HAMAMELIS VIRGINIANA TOP WATER
- POTASSIUM HYDROXIDE
- POTASSIUM SORBATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68472-105 | 68472-105-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAMUSCULAR | 0.13 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / NASAL | 250 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, LIQUID FILLED / ORAL | 154 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER / ORAL | 275 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | EMULSION / OPHTHALMIC | 0.02 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / TOPICAL | 0.3 %w/w | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / RECTAL | 1808 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 15eb367a-9154-44dd-99f1-a2a995057523 | d0db8c4e-2e41-41dd-81fb-65e008b96acd | 2012-05-02 | Warnings | 15eb367a-9154-44dd-99f1-a2a995057523 d0db8c4e-2e41-41dd-81fb-65e008b96acd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.